Substance

ID:348841

Names and Identifiers
IUPAC Traditional name
N,N-dimethyl-5-[(4-phenylphenyl)methyl]-1,2,3,4-tetrazole-1-carboxamide
IUPAC name
N,N-dimethyl-5-[(4-phenylphenyl)methyl]-1H-1,2,3,4-tetrazole-1-carboxamide
Synonyms
5-Biphenyl-4-ylmethyl-tetrazole-1-carboxylic acid dimethylamideLY21832401H-Tetrazole-1-carboxamide, 5-([1,1′-biphenyl]-4-ylmethyl)-N,N-dimethyl-
Registration numbers
CAS Number
MDL Number
Properties
Safety Information
GHS Hazard statements
H302
Risk Statements
22
German water hazard class
3
Storage Condition
desiccated
GHS Pictograms
GHS07
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
MSDS Link
GHS Signal Word
Warning
European Hazard Symbols
Harmful Harmful (Xn)
Storage Temperature
2-8°C
Product Information
Purity
≥98% (HPLC)
Empirical Formula (Hill Notation)
C17H17N5O
Physical Property
Solubility
DMSO: >10 mg/mL
Molecule Details
Biochem/physiol Actions
Regioisomer 1-5 of LY2183240 is a potent inhibitor of anandamide uptake (IC50= 15 nM). The compound inhibits FAAH (IC50=2.1 nM) and some other brain serine proteases. After systemic administration to rodents, LY2182340 elevates brain anandamide levels and shows efficacy in a rodent model of persistent pain (ED50=1.37 mg/kg). Regioisomer 2-5 of LY2183240 is less active. The compound is more potent than N-(4-Hydroxyphenyl)-arachidonylamide (AM-404), which inhibits anandamide transport at IC50=1mM.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data